FDA Approves New Diabetes Drug, First in its Class

A few weeks ago, the FDA approved Invokana (canagliflozin), the first drug in a new class of drugs called sodium-glucose co-transporter 2 inhibitors (SGLT2). Canagliflozin is a tablet taken once daily before the first meal of the day that when added to diet and exercise is shown to improve glycemic control in adults with type 2 diabetes mellitus. Read the full online story here>>

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s